NCT06910202

Brief Summary

In 2009, the FDA banned all flavored conventional cigarettes except menthol. While no such ban exists for e-cigarettes, proposals have emerged in several regions. Flavors are key targets for tobacco control policy, making it crucial to understand their role in substitution.The first wave of the PATH study found that 80% of youth, 73% of young adults, and 29% of older smokers used flavored products. Over 80% of young adults first used flavored tobacco, compared to about 50% of adults. Among ever-users, current tobacco use was 32% higher if their first product was flavored.One study reported that 75% of flavored product users would quit if flavors were removed. These findings highlight the importance of user type in shaping policy and raise the question of whether banning flavors would increase quitting or drive substitution. The Experimental Tobacco Marketplace (ETM) is a novel method for estimating the effects of new tobacco policies and products on consumption and substitution. By experimentally controlling product mix, prices, and policies, ETM simulates "real-world" conditions to assess potential policy impacts.This methodology has been used to study various policies in adult smokers under this grant: nicotine dose variations (Study 1), tobacco taxes and subsidies (Study 2), and workplace restrictions (Study 3). Study 1 found that cigarette and e-cigarette substitutability increased with e-liquid nicotine strength, with 24mg/mL showing the highest substitution. Study 2 showed that cigarette taxes reduced cigarette purchases and increased e-liquid purchases, while e-liquid subsidies increased e-liquid purchases but did not affect cigarette consumption. No study to date has experimentally examined the effects of flavored tobacco products availability on consumer behavior. The rationale for this specific proposal is to explore prospectively the possible consequences of a flavor ban on consumption and substitution with tobacco products. The results might inform tobacco control policies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 8, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2022

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

March 7, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
8 months until next milestone

Results Posted

Study results publicly available

December 9, 2025

Completed
Last Updated

December 9, 2025

Status Verified

February 1, 2025

Enrollment Period

10 months

First QC Date

March 7, 2025

Results QC Date

September 12, 2025

Last Update Submit

December 8, 2025

Conditions

Keywords

CigarettesE-cigarettesExperimental Tobacco MarketplaceSubstitutabilityFlavors

Outcome Measures

Primary Outcomes (1)

  • Nicotine/Tobacco Products Substitution

    The outcome measure of substitution will be collected and modeled using a virtual store. Participants will complete purchasing trials in an Experimental Tobacco Marketplace (ETM) with cigarettes increasing in price (cigarette type depending on condition). Other product prices will remain at market price. Substitutability occurs as a function of different flavor conditions. The degree to which other nicotine/tobacco products substitute for usual cigarettes under varying price and flavor restriction conditions will be assessed. Mixed-effects hierarchical linear regression will be used to evaluate purchasing behavior. The model includes a three-way interaction (cigarette policy Ă— e-cigarette policy Ă— log(price)) and a random effect for participant. Model selection based on Bayesian Information Criterion (BIC).

    During the intervention, session 2 (1 day per participant)

Study Arms (1)

Menthol cigarette smokers

EXPERIMENTAL

Menthol cigarette smokers will complete questionnaires on a computer, sample a range of tobacco products, and purchase tobacco products in an online store under four different scenarios: a) cigarette flavor restricted and e-cigarette flavor restricted, b) cigarette flavor unrestricted and e-cigarette flavor restricted, c) cigarette flavor restricted and e-cigarette flavor unrestricted, d) cigarette flavor unrestricted and e-cigarette flavor unrestricted.

Behavioral: Manipulation of nicotine/tobacco product price and availability

Interventions

This study does involve experimental manipulation of nicotine/tobacco product price and availability to understand consumers' behavior. Participants will be provided with a commercially available e-cigarette to use during the study, if they wish. Every participant will purchase tobacco products in an online store under four different scenarios: a) cigarette flavor restricted and e-cigarette flavor restricted, b) cigarette flavor unrestricted and e-cigarette flavor restricted, c) cigarette flavor restricted and e-cigarette flavor unrestricted, d) cigarette flavor unrestricted and e-cigarette flavor unrestricted.

Menthol cigarette smokers

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be between 21 and 65 years of age
  • Cigarette smokers
  • Smoke cigarettes daily (≥ 5 cigarettes/day)
  • Do not use e-cigarettes regularly (no more than 9 times in the last month)
  • Be willing to try e-cigarettes

You may not qualify if:

  • Pregnant or lactating women
  • Plans to move out of the area
  • Use of prescription medication that might affect smoking or nicotine metabolism
  • Unmanaged medical or psychiatric conditions
  • Plans to quit smoking within the next 30 days
  • This study will focus on cigarette smokers and dual users. We will not include individuals under the age of 21 in compliance with Virginia state law. Minors, pregnant women, prisoners, and adults not capable to consent on their own behalf will be excluded from this study.
  • Minors, as defined by state law where the study is performed (infants, children, teenagers)
  • Pregnant women (can be included in minimal risk studies by mentioning in section 13.1)
  • Prisoners (including all incarcerated individuals)
  • Adults not capable to consent on their own behalf

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, 24016, United States

Location

Related Publications (8)

  • Pope DA, Poe L, Stein JS, Kaplan BA, DeHart WB, Mellis AM, Heckman BW, Epstein LH, Chaloupka FJ, Bickel WK. The Experimental Tobacco Marketplace: Demand and Substitutability as a Function of Cigarette Taxes and e-Liquid Subsidies. Nicotine Tob Res. 2020 Apr 21;22(5):782-790. doi: 10.1093/ntr/ntz116.

    PMID: 31350894BACKGROUND
  • Pope DA, Poe L, Stein JS, Kaplan BA, Heckman BW, Epstein LH, Bickel WK. Experimental tobacco marketplace: substitutability of e-cigarette liquid for cigarettes as a function of nicotine strength. Tob Control. 2019 Mar;28(2):206-211. doi: 10.1136/tobaccocontrol-2017-054024. Epub 2018 Apr 18.

    PMID: 29669748BACKGROUND
  • Bickel WK, Pope DA, Kaplan BA, DeHart WB, Koffarnus MN, Stein JS. Electronic cigarette substitution in the experimental tobacco marketplace: A review. Prev Med. 2018 Dec;117:98-106. doi: 10.1016/j.ypmed.2018.04.026. Epub 2018 Apr 24.

    PMID: 29702131BACKGROUND
  • Harrell MB, Loukas A, Jackson CD, Marti CN, Perry CL. Flavored Tobacco Product Use among Youth and Young Adults: What if Flavors Didn't Exist? Tob Regul Sci. 2017 Apr;3(2):168-173. doi: 10.18001/TRS.3.2.4.

    PMID: 28775996BACKGROUND
  • Villanti AC, Johnson AL, Ambrose BK, Cummings KM, Stanton CA, Rose SW, Feirman SP, Tworek C, Glasser AM, Pearson JL, Cohn AM, Conway KP, Niaura RS, Bansal-Travers M, Hyland A. Flavored Tobacco Product Use in Youth and Adults: Findings From the First Wave of the PATH Study (2013-2014). Am J Prev Med. 2017 Aug;53(2):139-151. doi: 10.1016/j.amepre.2017.01.026. Epub 2017 Mar 16.

    PMID: 28318902BACKGROUND
  • Providenceri.com. Providence Tobacco Laws Go Into Effect January 3. Healthy Communities 2013. https://www.providenceri.com/healthy-communities/providence-tobacco-laws-go-into-effect-january-3.

    BACKGROUND
  • FOX32News. Illinois attorney general: ban e-cigarette flavors. 2014. http://www.myfoxchicago.com/story/26238470/illinois-attorney-general-ban-e-cigarette-flavors. Accessed 11-3-14.

    BACKGROUND
  • Durkin E. Bill would ban sale of flavored e-cigarettes. Celeste Katz Daily Politics. New York: New York Daily News; 2014.

    BACKGROUND

MeSH Terms

Conditions

Cigarette SmokingVaping

Condition Hierarchy (Ancestors)

Tobacco SmokingSmokingBehaviorTobacco Use

Limitations and Caveats

This project is a secondary analysis of data originally collected under IRB#20-008. The study was originally designed as a four-arm trial with 100 planned participants and began before COVID-19. Due to funding and safety constraints, data were collected only from exclusive smokers (n=25). Seven cases were lost due to a survey error and treated as missing at random, and we had some trials with only 24 data points for analysis. The secondary analysis protocol was approved (VT IRB#25-185).

Results Point of Contact

Title
Dr. Roberta Freitas Lemos
Organization
Fralin Biomedical Research Institute at VTC

Study Officials

  • Roberta Freitas Lemos, Ph.D.

    Fralin Biomedical Research Institute at VTC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2025

First Posted

April 4, 2025

Study Start

July 8, 2021

Primary Completion

May 18, 2022

Study Completion

May 25, 2022

Last Updated

December 9, 2025

Results First Posted

December 9, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations